How to Check Manipal Health Enterprises IPO Allotment Status
Last Updated: 3rd August 2026 - 04:29 pm
Manipal Health Enterprises Limited is one of India's leading multi-speciality hospital chains, offering tertiary and quaternary healthcare services across a wide range of medical specialities.
The company operates an integrated healthcare network comprising hospitals, outpatient centres, diagnostics, pharmacies and home-care services. Its hospitals provide services across cardiology, oncology, neurosciences, orthopaedics, organ transplantation, gastroenterology, nephrology, paediatrics and critical care.
With a strong presence across major Indian cities, Manipal Health focuses on advanced clinical care, digital healthcare initiatives and expanding access to quality medical services through its extensive hospital network.
Manipal Health Enterprises IPO is a book-built mainboard issue. The IPO opened for subscription on July 29, 2026 and closed on July 31, 2026. The basis of allotment is expected to be finalised on August 3, 2026, while the shares are proposed to be listed on BSE and NSE.
Manipal Health Enterprises IPO Subscription Status
Manipal Health Enterprises IPO was subscribed 5.10 times on July 31, 2026, based on the final day subscription data. The issue witnessed strong participation from Qualified Institutional Buyers (QIBs), while demand from retail and NII investors remained comparatively moderate.
| Date | QIB | NII | Retail | EMP | Total |
|---|---|---|---|---|---|
| Day 1 (July 29) | 0.15 | 0.08 | 0.26 | 0.94 | 0.15 |
| Day 2 (July 30) | 0.62 | 0.15 | 0.48 | 1.54 | 0.47 |
| Day 3 (July 31) | 8.54 | 1.05 | 0.90 | 2.28 | 5.10 |
The QIB category recorded the strongest demand, closing at 8.54 times subscription.
The NII portion was subscribed 1.05 times, while the retail category closed at 0.90 times.
The employee portion received 2.28 times subscription.
Manipal Health Enterprises IPO Share Price and Investment Details
Manipal Health Enterprises IPO is a mainboard public issue proposed to be listed on BSE and NSE. The issue witnessed robust institutional participation during the final day of bidding, helping overall subscription reach 5.10 times. Strong QIB demand generally reflects institutional confidence, although listing performance will ultimately depend on broader market conditions and investor sentiment.
Utilisation of IPO Proceeds
The company proposes to utilise the net proceeds from the fresh issue primarily for repayment or prepayment of certain outstanding borrowings, funding capital expenditure for hospital expansion and medical infrastructure, supporting strategic growth initiatives, and meeting general corporate purposes. The offer-for-sale proceeds will be received by the selling shareholders.
Business Overview
Manipal Health Enterprises is among India's largest integrated healthcare providers, operating a diversified network of multi-speciality hospitals that offer advanced tertiary and quaternary care. Its business model is supported by a broad portfolio of clinical specialities, experienced medical professionals and a growing presence across key healthcare markets.
The company benefits from favourable long-term industry trends, including rising healthcare expenditure, increasing health insurance penetration, ageing demographics and growing demand for organised private healthcare services. Continuous investments in hospital infrastructure, technology adoption and clinical excellence have strengthened its position within India's healthcare sector.
Key strengths include a well-recognised healthcare brand, extensive hospital network, diversified speciality offerings, experienced clinical team, integrated healthcare ecosystem and strong institutional backing.
Investors should also consider risks associated with regulatory changes in the healthcare sector, high capital expenditure requirements, doctor retention, occupancy utilisation, competitive intensity among private hospital chains and execution risks related to expansion projects.
- FREE IPO Application
- Apply with Ease
- Pre-Apply for IPOs
- UPI Bid Instantly
Trending on 5paisa
03
5paisa Capital Ltd
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.